2 ms·
This is a great and interesting point, but it's very misleading in this case. The pharma exec isn't making the argument you describe in any way. In fact, he cla
by darkerside 7y ago
This is a great and interesting point, but it's very misleading in this case. The pharma exec isn't making the argument you describe in any way. In fact, he claims he is being misquoted, which is either true or a backtrack, and that while "morality" was discussed in the conversation, he never claimed raising prices was moral.
- kryogen1c 7y ago>In fact, he claims he is being misquoted TFA says he says this, but it looks like PR spin to me. He is refuting the word choice, but his underlying point is the same. "Mulye went on to say he "nearly went bankrupt" twice and that he lost money after buying a plant in Ohio, which he said employs just under 100 people. " "Is it moral for me to lose money?" Mulye asked. "If I don't make money, then I can't create those jobs. And where does the money go when I make it? It goes back into research and hiring new people right here in the US."
- JustSomeNobody 7y ago> And where does the money go when I make it? It goes back into research and hiring new people right here in the US." Probably closer to the truth that it goes to shareholders, but, okay.
- darkerside 7y agoYou're likely right that it's PR spin, but the answer for that is responding to the spin, not ignoring the content of the article like many comments were doing at the time.